Data gathered: December 7
AI Stock Analysis - ANI Pharmaceuticals (ANIP)
Analysis generated October 6, 2024. Powered by Chat GPT.
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. The company's capabilities include product development, manufacturing, and marketing, with an emphasis on niche markets and high-barrier to entry products. ANI Pharmaceuticals is headquartered in Baudette, Minnesota.
Stock Alerts - ANI Pharmaceuticals (ANIP)
 |
ANI Pharmaceuticals | November 28 Insider Alert: Lalwani Nikhil is selling shares |
|
ANI Pharmaceuticals | November 20 Employee Rating is down by 2.7% over the last month. |
|
ANI Pharmaceuticals | November 19 Insider Alert: Mutz Christopher is selling shares |
|
ANI Pharmaceuticals | November 15 Insider Alert: Cook Meredith is selling shares |
Alternative Data for ANI Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 29 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 44,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 23 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 55 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,062 | Sign up | Sign up | Sign up |
| Twitter Mentions | 26 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 57 | Sign up | Sign up | Sign up |
| Linkedin Employees | 498 | Sign up | Sign up | Sign up |
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
| Price | $56.97 |
| Target Price | Sign up |
| Volume | 403,190 |
| Market Cap | $1.2B |
| Year Range | $54.32 - $69.13 |
| Dividend Yield | 0% |
| PE Ratio | 49.06 |
| Analyst Rating | 75% buy |
| Industry | Biotechnology |
In the news
 |
Public Sector Pension Investment Board Increases Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)December 6 - ETF Daily News |
|
Analysts Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) PT at $77.33December 4 - ETF Daily News |
Intrauterine Devices Market Report Forecasts and Company Analysis 2024-2032, Profiles of AbbVie, Bayer, Teva Pharmaceuticals, ANI Pharmaceuticals, Mylan, CooperSurgical. and DKT InternationalDecember 4 - GlobeNewswire |
|
 |
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?December 2 - Yahoo |
|
Bank of Montreal Can Invests $13.04 Million in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)December 1 - ETF Daily News |
|
ANI Pharmaceuticals (NASDAQ:ANIP) Shares Gap Down on Insider SellingNovember 29 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 141M | 158M | -17M | -24M | -4.8M | 1.340 |
| Q2 '24 | 138M | 125M | 13M | -2.3M | 20M | 1.020 |
| Q1 '24 | 135M | 112M | 24M | 18M | 47M | 1.210 |
| Q4 '23 | 123M | 113M | 9.8M | 1.2M | 25M | 1.000 |
| Q3 '23 | 124M | 105M | 18M | 9.9M | 35M | 1.270 |
Insider Transactions View All
| Lalwani Nikhil filed to sell 370,378 shares at $58.3. November 27 '24 |
| Lalwani Nikhil filed to sell 373,859 shares at $58. November 27 '24 |
| Mutz Christopher filed to sell 76,777 shares at $57.7. November 18 '24 |
| Cook Meredith filed to sell 56,238 shares at $61.4. November 14 '24 |
| Cook Meredith filed to sell 56,488 shares at $57.2. October 15 '24 |
Similar companies
Read more about ANI Pharmaceuticals (ANIP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ANI Pharmaceuticals?
The Market Cap of ANI Pharmaceuticals is $1.2B.
What is ANI Pharmaceuticals' PE Ratio?
As of today, ANI Pharmaceuticals' PE (Price to Earnings) ratio is 49.06.
What is the current stock price of ANI Pharmaceuticals?
Currently, the price of one share of ANI Pharmaceuticals stock is $56.97.
How can I analyze the ANIP stock price chart for investment decisions?
The ANIP stock price chart above provides a comprehensive visual representation of ANI Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ANI Pharmaceuticals shares. Our platform offers an up-to-date ANIP stock price chart, along with technical data analysis and alternative data insights.
Does ANIP offer dividends to its shareholders?
As of our latest update, ANI Pharmaceuticals (ANIP) does not offer dividends to its shareholders. Investors interested in ANI Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ANI Pharmaceuticals?
Some of the similar stocks of ANI Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.